Your browser doesn't support javascript.
loading
Stereotactic Ablative Radiation for Systemic Therapy-naïve Oligometastatic Kidney Cancer.
Hannan, Raquibul; Christensen, Michael; Christie, Alana; Garant, Aurelie; Pedrosa, Ivan; Robles, Liliana; Mannala, Samantha; Wang, Chiachien; Hammers, Hans; Arafat, Waddah; Courtney, Kevin; Bowman, Isaac A; Sher, David; Ahn, Chul; Cole, Suzanne; Choy, Hak; Timmerman, Robert; Brugarolas, James.
Afiliação
  • Hannan R; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: Raquibul.Hannan@utsouthwestern.edu.
  • Christensen M; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Christie A; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Garant A; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Pedrosa I; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Radiology, University of Texas Southwestern, Dallas, TX, USA.
  • Robles L; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Mannala S; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Wang C; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Hammers H; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine, Hematology-Oncology Division, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Arafat W; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine, Hematology-Oncology Division, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Courtney K; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine, Hematology-Oncology Division, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Bowman IA; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine, Hematology-Oncology Division, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Sher D; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Ahn C; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Cole S; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine, Hematology-Oncology Division, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Choy H; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Timmerman R; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: Robert.Timmerman@utsouthwestern.edu.
  • Brugarolas J; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine, Hematology-Oncology Division, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: James.Brugarolas@utsouthw
Eur Urol Oncol ; 5(6): 695-703, 2022 12.
Article em En | MEDLINE | ID: mdl-35985982
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Cuidados_paliativos / Geral / Prevencao_e_fatores_de_risco / Agentes_cancerigenos / Tipos_de_cancer / Outros_tipos / Tratamento / Radioterapia Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Radiocirurgia / Neoplasias Renais Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Eur Urol Oncol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Cuidados_paliativos / Geral / Prevencao_e_fatores_de_risco / Agentes_cancerigenos / Tipos_de_cancer / Outros_tipos / Tratamento / Radioterapia Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Radiocirurgia / Neoplasias Renais Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Eur Urol Oncol Ano de publicação: 2022 Tipo de documento: Article